Across the EU, cannabinoid extracts including CBN are classified as unauthorised novel foods under Regulation (EU) 2015/2283, and no Union list authorisation exists in any member state.

In Latvia that question has been overtaken by a narcotics one. Latvia's controlled-substance schedules sit in the annex to the likums Par Krimināllikuma spēkā stāšanās un piemērošanas kārtību - primary legislation, since the schedules were moved there on 1 June 2021 and the earlier Cabinet regulation repealed. On 13 November 2025 the Saeima amended the generic dibenzopirāni group in List I, the prohibited and most restricted tier, to read: Kanabinols un no kanabinola un kanabidiola atvasināti savienojumi (izņemot kanabidiolu). The amendment was proclaimed on 21 November 2025 and took effect on 1 December 2025. Cannabinol is now named in its own right, with cannabidiol the only substance expressly excepted.

Under article 5 of the law on the legal circulation of narcotic and psychotropic substances it is prohibited to cultivate, produce, manufacture, import, export, distribute, advertise, transport, store, transfer for consideration or otherwise, acquire, use or send through Latvian territory anything in List I. Article 1 defines importation as physical movement into Latvia from the territory of any other state, so intra-EU consignments are caught, and defines distribution to include movement across the state border. Criminal liability follows under articles 253, 253.1 and 253.2 of the Criminal Law, which name pārsūtīšana - dispatch - in their own terms.